Skip to main content
Springer Nature Link
Account
Fig. 1 | BMC Cancer

Fig. 1

From: Berberine: a promising strategy to combat cetuximab-resistance in colorectal cancer

Fig. 1

Analysis of CRC cell line sensitivity to cetuximab and EGFR expression in CRC cells. (A) Cetuximab response curves in 9 CRC cell lines. Cell lines were treated with increasing concentrations of cetuximab for 72 h, and cell viability was assessed by CCK assay. (B) Inhibition rate of 9 CRC cell lines treated with cetuximab at 10 µg/ml for 72 h. (C) Expression of EGFR protein in 9 CRC cells tested by immunoblotting assay. (D) Quantification of EGFR protein in 9 CRC cell lines

Back to article page